摘要
Essential thrombocytosis (ET) is a rare myeloproliferative disorder, which is a major risk factor for thrombosis and bleeding, which complicates cardiovascular surgery. ET is a risk factor for coronary artery disease that should be treated. We present a case of a male with ET who underwent coronary artery bypass grafting (CABG) at the University Hospital of the West Indies, and died post-surgery. Post mortem revealed early graft thrombosis. We believe that post<span style="font-family:Verdana;">-</span><span style="font-family:Verdana;">operative aspirin therapy maybe would have prevented this fatal outcome.</span>
Essential thrombocytosis (ET) is a rare myeloproliferative disorder, which is a major risk factor for thrombosis and bleeding, which complicates cardiovascular surgery. ET is a risk factor for coronary artery disease that should be treated. We present a case of a male with ET who underwent coronary artery bypass grafting (CABG) at the University Hospital of the West Indies, and died post-surgery. Post mortem revealed early graft thrombosis. We believe that post<span style="font-family:Verdana;">-</span><span style="font-family:Verdana;">operative aspirin therapy maybe would have prevented this fatal outcome.</span>
作者
Joseph L. Blidgen
Clarence D. McGaw
Joseph L. Blidgen;Clarence D. McGaw(Department of Surgery, Radiology, Anesthesia and Intensive Care, University of the West Indies, Mona P.O., Kingston, Jamaica)
